Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8201 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8013 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.795 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7606 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7588 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7588 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7569 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD2629 |
Approved |
0.755 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7547 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7519 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7515 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7415 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7358 |
Intermediate Similarity |
NPD37 |
Approved |
0.7357 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7357 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7346 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7234 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7186 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7088 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7610 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.702 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD8313 |
Approved |
0.6994 |
Remote Similarity |
NPD8312 |
Approved |
0.6989 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD5494 |
Approved |
0.6977 |
Remote Similarity |
NPD6765 |
Approved |
0.6977 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6977 |
Remote Similarity |
NPD7240 |
Approved |
0.6977 |
Remote Similarity |
NPD6764 |
Approved |
0.6962 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD3226 |
Approved |
0.6957 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD5402 |
Approved |
0.6948 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.694 |
Remote Similarity |
NPD164 |
Approved |
0.6933 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6909 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6903 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1238 |
Approved |
0.689 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.689 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD3750 |
Approved |
0.6879 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6879 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6878 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD7411 |
Suspended |
0.6867 |
Remote Similarity |
NPD7095 |
Approved |
0.6866 |
Remote Similarity |
NPD1929 |
Approved |
0.6866 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD1930 |
Approved |
0.6864 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD6799 |
Approved |
0.6853 |
Remote Similarity |
NPD9545 |
Approved |
0.6848 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6839 |
Remote Similarity |
NPD2438 |
Suspended |
0.6839 |
Remote Similarity |
NPD5405 |
Approved |
0.6839 |
Remote Similarity |
NPD5404 |
Approved |
0.6839 |
Remote Similarity |
NPD5406 |
Approved |
0.6839 |
Remote Similarity |
NPD5408 |
Approved |
0.6832 |
Remote Similarity |
NPD5403 |
Approved |
0.6829 |
Remote Similarity |
NPD1934 |
Approved |
0.6826 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6818 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD6784 |
Approved |
0.6818 |
Remote Similarity |
NPD6785 |
Approved |
0.6813 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD5401 |
Approved |
0.6812 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6795 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6795 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6795 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6795 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD5763 |
Approved |
0.6795 |
Remote Similarity |
NPD5762 |
Approved |
0.6795 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD4806 |
Approved |
0.6781 |
Remote Similarity |
NPD4807 |
Approved |
0.6776 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6774 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6774 |
Remote Similarity |
NPD3748 |
Approved |
0.6767 |
Remote Similarity |
NPD2066 |
Phase 3 |
0.6766 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD5306 |
Approved |
0.6759 |
Remote Similarity |
NPD5305 |
Approved |
0.6752 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6741 |
Remote Similarity |
NPD6647 |
Phase 2 |
0.674 |
Remote Similarity |
NPD6534 |
Approved |
0.674 |
Remote Similarity |
NPD6535 |
Approved |
0.6739 |
Remote Similarity |
NPD4061 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6732 |
Remote Similarity |
NPD4140 |
Approved |
0.6731 |
Remote Similarity |
NPD6099 |
Approved |
0.6731 |
Remote Similarity |
NPD6100 |
Approved |
0.6725 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6724 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6721 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6721 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.672 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6715 |
Remote Similarity |
NPD6685 |
Approved |
0.6714 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6711 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD3882 |
Suspended |
0.6707 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6706 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6691 |
Remote Similarity |
NPD5909 |
Discontinued |
0.6691 |
Remote Similarity |
NPD5955 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD2801 |
Approved |
0.6684 |
Remote Similarity |
NPD8319 |
Approved |
0.6684 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD7714 |
Approved |
0.6667 |
Remote Similarity |
NPD7715 |
Approved |
0.6667 |
Remote Similarity |
NPD3749 |
Approved |
0.6667 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6647 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6644 |
Remote Similarity |
NPD3019 |
Approved |
0.6644 |
Remote Similarity |
NPD1283 |
Approved |
0.6642 |
Remote Similarity |
NPD7798 |
Approved |
0.6628 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6624 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6624
|
Remote Similarity |
NPD2796 |
Approved |